Explore / Clinical trial
Clinical trial

Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis

State University of New York at BuffaloCompletedPhase 4Started Aug 1, 201530 enrolledUnited StatesNCT03046251

Abstract

The purpose of this study is to evaluate if monthly natalizumab, initiated after delivery, is effective in preventing postpartum relapses.

Keywords

Multiple Sclerosis

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.